Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvoxamine for depression in patients with cancer
ChiCTR2000030498Phase 4Completed
- Sponsor
- Tongji Hospital
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fluvoxamine in major depressive disorder (MDD), sponsored by Tongji Hospital. Primary endpoint: Hamilton Depression Scale. Started Oct 2016; status: completed.
02
Drugs
fluvoxamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR2000030498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030498.